Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 9 studies | 19% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 1317.31 | 578 / 578 | 78% | 3.27 | 896 / 1155 |
stomach | 90% | 280.45 | 323 / 359 | 58% | 2.19 | 167 / 286 |
breast | 86% | 316.24 | 396 / 459 | 62% | 2.62 | 690 / 1118 |
thymus | 90% | 461.60 | 589 / 653 | 44% | 4.88 | 269 / 605 |
uterus | 76% | 177.76 | 130 / 170 | 53% | 1.70 | 244 / 459 |
intestine | 72% | 733.65 | 693 / 966 | 50% | 1.58 | 265 / 527 |
esophagus | 63% | 144.39 | 908 / 1445 | 56% | 1.93 | 102 / 183 |
prostate | 81% | 263.56 | 198 / 245 | 37% | 0.93 | 184 / 502 |
skin | 53% | 148.33 | 955 / 1809 | 61% | 3.58 | 289 / 472 |
kidney | 52% | 241.27 | 46 / 89 | 62% | 2.43 | 560 / 901 |
bladder | 71% | 381.90 | 15 / 21 | 41% | 1.25 | 206 / 504 |
spleen | 100% | 2764.06 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 96% | 521.16 | 1159 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 93% | 13.57 | 27 / 29 |
liver | 65% | 134.18 | 148 / 226 | 24% | 0.70 | 99 / 406 |
peripheral blood | 89% | 2360.59 | 829 / 929 | 0% | 0 | 0 / 0 |
pancreas | 13% | 20.17 | 42 / 328 | 62% | 2.94 | 110 / 178 |
tonsil | 0% | 0 | 0 / 0 | 73% | 4.06 | 33 / 45 |
ovary | 28% | 61.92 | 50 / 180 | 23% | 0.43 | 99 / 430 |
blood vessel | 50% | 161.44 | 664 / 1335 | 0% | 0 | 0 / 0 |
adrenal gland | 30% | 49.40 | 78 / 258 | 9% | 0.17 | 20 / 230 |
heart | 30% | 64.18 | 259 / 861 | 0% | 0 | 0 / 0 |
brain | 7% | 12.33 | 182 / 2642 | 13% | 0.57 | 95 / 705 |
eye | 0% | 0 | 0 / 0 | 6% | 0.17 | 5 / 80 |
muscle | 3% | 5.54 | 25 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0046629 | Biological process | gamma-delta T cell activation |
GO_0007165 | Biological process | signal transduction |
GO_0050853 | Biological process | B cell receptor signaling pathway |
GO_0006968 | Biological process | cellular defense response |
GO_0001865 | Biological process | NK T cell differentiation |
GO_0050852 | Biological process | T cell receptor signaling pathway |
GO_0002250 | Biological process | adaptive immune response |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0001819 | Biological process | positive regulation of cytokine production |
GO_0006468 | Biological process | protein phosphorylation |
GO_0042110 | Biological process | T cell activation |
GO_0005886 | Cellular component | plasma membrane |
GO_0005911 | Cellular component | cell-cell junction |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0004715 | Molecular function | non-membrane spanning protein tyrosine kinase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | ITK |
Protein name | Tyrosine-protein kinase ITK/TSK (EC 2.7.10.2) (Interleukin-2-inducible T-cell kinase) (IL-2-inducible T-cell kinase) (Kinase EMT) (T-cell-specific kinase) (Tyrosine-protein kinase Lyk) IL2 inducible T cell kinase |
Synonyms | LYK EMT |
Description | FUNCTION: Tyrosine kinase that plays an essential role in regulation of the adaptive immune response. Regulates the development, function and differentiation of conventional T-cells and nonconventional NKT-cells. When antigen presenting cells (APC) activate T-cell receptor (TCR), a series of phosphorylation lead to the recruitment of ITK to the cell membrane, in the vicinity of the stimulated TCR receptor, where it is phosphorylated by LCK. Phosphorylation leads to ITK autophosphorylation and full activation. Once activated, phosphorylates PLCG1, leading to the activation of this lipase and subsequent cleavage of its substrates. In turn, the endoplasmic reticulum releases calcium in the cytoplasm and the nuclear activator of activated T-cells (NFAT) translocates into the nucleus to perform its transcriptional duty. Phosphorylates 2 essential adapter proteins: the linker for activation of T-cells/LAT protein and LCP2. Then, a large number of signaling molecules such as VAV1 are recruited and ultimately lead to lymphokine production, T-cell proliferation and differentiation . Required for TCR-mediated calcium response in gamma-delta T-cells, may also be involved in the modulation of the transcriptomic signature in the Vgamma2-positive subset of immature gamma-delta T-cells (By similarity). Phosphorylates TBX21 at 'Tyr-530' and mediates its interaction with GATA3 (By similarity). . |
Accessions | A0A8V8TLR2 ENST00000696962.1 ENST00000521769.5 E5RJY4 E5RFR5 ENST00000517779.1 ENST00000422843.8 Q08881 |